In May, Novo Nordisk moved the Delhi HC against DRL, seeking that the Indian firm and its distributors be restrained from using, manufacturing, selling, distributing, advertising, exporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback